1. A category‐free approach to prognostic modelling in aggressive non‐Hodgkin B cell lymphomas based on large patient databases. (June 2017) Authors: Burton, C.; Sha, C.; Barrans, S.; Jack, A.; Painter, D.; Smith, A.; Roman, E.; Crouch, S.; Care, M.; Tooze, R.; Westhead, D. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 326 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. ACCEPT: A PHASE IB/II COMBINATION OF ACALABRUTINIB WITH RITUXIMAB, CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE AND PREDNISOLONE (R‐CHOP) FOR PATIENTS WITH DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL). (12th June 2019) Authors: Cummin, T.E.; Caddy, J.; Mercer, K.; Maishman, T.; Schuh, A.; Lopez Pascua, L.; Collins, G.; McMillan, A.; Ardeshna, K.; Galanopoulous, A.; Burton, C.; Barrans, S.; Griffiths, G.; Johnson, P.; Davies, A.J. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 71 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. ARGO: A RANDOMISED PHASE II STUDY OF ATEZOLIZUMAB WITH RITUXIMAB, GEMCITABINE AND OXALIPLATIN IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA WHO ARE NOT CANDIDATES FOR HIGH‐DOSE THERAPY. (12th June 2019) Authors: Davies, A.J.; Tansley Hancock, O.; Cummin, T.; Caddy, J.; Stanton, L.; Burton, C.; Barrans, S.; Coleman, A.; Osborne, W.; McKay, P.; Griffiths, G.; Johnson, P. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 555 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. CROSS‐PLATFORM VALIDATION OF GENE EXPRESSION PROFILING (GEP) BASED CELL OF ORIGIN (COO) CLASSIFICATION IN a CLINICAL LABORATORY SETTING. (June 2017) Authors: Burton, C.; Barrans, S.; Ahmed, S.; Bentley, M.A.; Clipson, A.; Wang, M.; Taylor, J.; Detute, R.; Westhead, D.R.; Care, M.A.; Du, M.Q.; Davies, A.; Johnson, P.W. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. DEFINING BURKITT‐LIKE LYMPHOMA WITH 11Q ABERRATION IN A SPECIALISED UK HAEMATOPATHOLOGY DIAGNOSTIC SERVICE. (12th June 2019) Authors: Barrans, S.; Painter, D.; van Hoppe, S.; Smith, A.; Sha, C.; Cucco, F.; Du, M.; Westhead, D.; Davies, A.; Johnson, P.; Roman, E.; Burton, C. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 143 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. DIFFERENTIAL EFFICACY OF BORTEZOMIB IN SUBTYPES OF DIFFUSE LARGE B‐CELL LYMPHOMA (DLBL): a PROSPECTIVE RANDOMISED STUDY STRATIFIED BY TRANSCRIPTOME PROFILING: REMODL‐B. (June 2017) Authors: Davies, A.J.; Barrans, S.; Maishman, T.; Cummin, T.E.; Bentley, M.; Mamot, C.; Novak, U.; Caddy, J.; Hamid, D.; Kazmi‐Stokes, S.H.; Mcmillan, A.; Fields, P.A.; Pocock, C.; Kruger, A.; Collins, G.; Sha, C.; Clipson, A.; Wang, M.; Tooze, R.M.; Care, M.A. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 130 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. DNMT3A‐2 EXPRESSION LEVELS CHARACTERISE DIFFUSE LARGE B‐CELL LYMPHOMA WITH DISTINCT METHYLATION PATTERNS AND OUTCOME. (June 2017) Authors: Kuhnl, A.; Shaikh, R.; Cunningham, D.; Counsell, N.; Barrans, S.; Burton, C.; Bentley, M.; Gleeson, M.; Edwards, L.; Ulrich, L.; Smith, P.; Clifton‐Hadley, L.; Schofield, O.; Lawrie, A.; Linch, D.; Hubank, M.; Kaiser, M. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 154 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. GENE EXPRESSION PROFILING AND MUTATION ANALYSIS CAN AID TREATMENT DECISION MAKING IN AGGRESSIVE B CELL LYMPHOMA PATIENTS. (June 2017) Authors: Burton, C.H.; Barrans, S.; Van Hoppe, S.; Sha, C.; Taylor, J.; Evans, P.; Painter, D.; Smith, A.; Crouch, S.; Goodlad, J.R.; Roman, E.; Westhead, D.; Davies, A.; Johnson, P.W. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 156 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. HIGH EXPRESSION OF BCL‐2 AND BCL‐XL IN DIFFUSE LARGE B‐CELL LYMPHOMA CONFER POOR PROGNOSIS BUT MAY BE REVERSIBLE BY COMBINED INHIBITION WITH BET INHIBITORS AND BH3 MIMETICS. (12th June 2019) Authors: Cummin, T.E.; Cox, K.; Murray, T.; Barrans, S.; Sha, C.; Westhead, D.; Burton, C.; Davies, A.; Cragg, M.; Johnson, P.; Carter, M. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 124 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Identifying somatic mutations in cell‐free DNA of aggressive lymphoma patients: First cell‐free DNA results from the molecular profiling for lymphoma (MaPLe) study. (June 2017) Authors: Lopez Pascua, L.D.; Ahmed, S.M.; Barrans, S.; Burton, C.; Clipson, A.J.; Cucco, F.; Cutts, A.; Dreau, H.; Du, M.; Joke, D.; Mizani, R.T.; Salminen, O.; Van Hoppe, M.; Vaughan‐Spickers, N.; Schuh, A.; Johnson, P.W. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 281 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗